Bacthera and Seres enter deal to manufacture gut infection-tackling biotherapeutic 12-Nov-2021 By Will Chu Bacthera, the joint venture between Chr. Hansen and Lonza, is to team up with Seres Therapeutics to manufacture Seres’ lead product candidate for recurrent Clostridioides difficile infection (rCDI).